CTA-Sticky-button.png clinicaltrialsyearbook+button

Preclinical Development Operations Summit 2017

31st October- 1st November, Boston

The inaugural Preclinical Development Operations Summit was a thought-provoking two days of engaging presentations, discussion and networking.

The focused, senior-level audience debated how best to improve the efficiency of their preclinical development operations, from lead to IND. Key themes included strategies for finding and qualifying preclinical vendors, best practices for collecting and formatting preclinical data and developing realistic timelines when working internationally.

Following on from this success, Arena International is pleased to announce that this unique event will be returning once again in November 2017.

The 2017 program aims to stay abreast of the latest industry trends and operational challenges in preclinical development so if you have an interesting topic proposal, please get in touch with the program director.


Event News

The importance of Toxicology research

Over the past few years, Toxicology has played a vital part in the screening of newly developed drugs before it can be used on humans. 

Innovation in Preclinical trials

In the early stages of drug innovation, it is important to identify the limitations associated with new innovations. Innovating new drugs and making them available to patients can be very difficult. There is a massive research emphasis on researching how medicines will work and how it will affect patients. Listed below, there are five stages which represent the research and development process when innovating a new medication.

2016 Event Gallery

Have a look at some photos from the Preclinical Development Operations Summit 2016

Who should attend this event?

The Preclinical Development Operations Summit is the only strategically focused preclinical development conference in the US.Primary delegates for this event are:VP/ Directors/ Heads of:Preclinical ResearchPreclinical DevelopmentIn-vivo PharmacologyProcurementR&DPreclinical SafetyToxicology

2016 Highlights

A truly unique event, the 1st Annual Preclinical Development Operations Summit offered attendees an exclusive insight into innovative solutions to the most pressing operational challenges biopharma companies experience from Lead to IND.

See what our 2016 Delegates said:

“DEHA understands the importance of drug development and risk mitigation. Maneuvering the intricacies of preclinical development is vital and the 1st Annual Preclinical Development Operations Summit in Boston provided a forum for experts to discuss and was informative” – DEHA